Roopa Industries Limited (BOM:530991)

India flag India · Delayed Price · Currency is INR
61.49
-0.59 (-0.95%)
At close: Jun 10, 2025
4.31%
Market Cap 483.65M
Revenue (ttm) 1.23B
Net Income (ttm) 20.35M
Shares Out 7.87M
EPS (ttm) 2.57
PE Ratio 23.93
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,327
Average Volume 3,589
Open 62.50
Previous Close 62.08
Day's Range 60.01 - 62.99
52-Week Range 47.26 - 114.90
Beta -0.40
RSI 51.27
Earnings Date May 30, 2025

About Roopa Industries

Roopa Industries Limited manufactures, markets, and sells bulk drugs and intermediaries in India and internationally. The company offers triphenylphosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3. It manufactures and exports glucosamine. The company was incorporated in 1985 and is based in Hyderabad, India. [Read more]

Industry Chemicals and Allied Products
Founded 1985
Employees 55
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530991
Full Company Profile

Financial Performance

In 2024, Roopa Industries's revenue was 1.23 billion, an increase of 72.28% compared to the previous year's 713.87 million. Earnings were 20.35 million, an increase of 33.95%.

Financial Statements

News

There is no news available yet.